Tag Archives: life sciences

3 Success tips for Life Science Commercial teams: Market Access, Part 2

  Address Payer Concerns, Cost and Efficacy in Advance¬† Considering the pressure to demonstrate effective patient outcomes at low cost, payers consider cost and efficacy when making decisions about which therapeutic interventions to add to their formulary. In addition to results from clinical trials, market

Data Partnerships crucial for Data Moat

Before a deep dive into data partnerships, it is imperative to define product strategy, user story, use cases and the competitive advantage aka the data moat.  While data is not the new oil, the right data strategy is critical for health and life sciences ML/AI

Data privacy tradeoffs for AI in Life Sciences

Covid -19 has changed the data privacy paradigm. What used to be controversial with regards to accessing and mining large data sets with Business Associate Agreements (BAA), due to ensuing consumer privacy backlash is beginning to become more acceptable. While we are still at baby

The NHS, a hot bed for Innovation in Life Sciences

Much is talked about health care distribution channels such as payers here in the US. Yet just across the atlantic, there is a payer that is just as important especially when it comes to testing AI in life sciences – the UK National Health Service